静注人免疫球蛋白在治疗新生儿感染性肺炎治疗与干预中的效果观察

Effect of Human Immunoglobulin for Intravenous Injection in the treatment and intervention of neonatal infectious pneumonia

目的 讨论静注人免疫球蛋白在治疗新生儿感染性肺炎治疗与干预中的效果。方法 选取2015年7月-2016年台州恩泽医疗中心（集团）台州医院接受治疗的100例新生儿出现感染性肺炎的患者,随机将其分为观察组和对照组,每组各50例,对照组使用常规治疗的方式,观察组在此基础上静注人免疫蛋白并且采取相应的护理措施。比较2组患儿的治疗总有效率、住院时间以及肺部湿啰音和呼吸困难消失的时间。结果 观察组患儿的治疗总有效率显著的高于对照组,2组患儿数据比较差异具有统计学意义（P〈0.05）;观察组患儿的住院时间以及肺部湿啰音和呼吸困难消失的时间明显优于对照组,2组患儿数据比较差异具有统计学意义（P〈0.05）。结论 对新生儿感染性肺炎的治疗,使用静注人免疫球蛋白,能够有效的促进治疗有效率的提高,同时有助于患儿的恢复,值得在临床上推广使用。

Objective To discuss the effect of Human Immunoglobulin for Intravenous Injection in the treatment of neonatal pneumonia treatment and intervention. Methods 100 cases of newborns in our hospital from July 2015 to 2016 to receive the treatment of infectious pneumonia patients, and were randomly divided into control group and observation group, 50 cases in each group. The control group used routine treatment, the observation group on the basis of intravenous immunoglobulin and take corresponding nursing measures. The treatment were compared between the two groups of the total efficiency of disappearance of hospitalization time and pulmonary rales and difficulty breathing time. Results In the control group than the treatment in the observation group the total efficiency significantly comparison between the two groups of children have statistical significance（P〈0.05）; disappeared in the observation group hospitalization time and pulmonary rales and dyspnea was significantly better on time According to the group, there were significant differences between the two groups have statistical significance（P〈0.05）. Conclusion The use of Human Immunoglobulin for Intravenous Injection on the treatment of neonatal pneumonia, can effectively promote the treatment efficiency, and is helpful to the patient＆#39;s recovery, worthy of promotion in clinical use.